IMA Revenue Breakdown
ImageneBio, Inc. (IMA). Quarter ended 2025-12-31 · 10-Q · every retained filed quarter remains available.
- 2025-12-31: Others Not split by product in the filing$800.00K100.00%; Total revenue $800.00K.
- 2024-12-31: Others Not split by product in the filing$3.50M100.00%; Total revenue $3.50M.
- 2023-12-31: Others Not split by product in the filing$9.16M100.00%; Total revenue $9.16M.
- 2022-12-31: Others Not split by product in the filing$15.62M100.00%; Total revenue $15.62M.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $800.00K 100.00% | $800.00K |
| 2024-12-31 | Not split by product in the filing $3.50M 100.00% | $3.50M |
| 2023-12-31 | Not split by product in the filing $9.16M 100.00% | $9.16M |
| 2022-12-31 | Not split by product in the filing $15.62M 100.00% | $15.62M |
| 2021-12-31 | Not split by product in the filing $30.98M 100.00% | $30.98M |
| 2020-12-31 | Not split by product in the filing $9.19M 100.00% | $9.19M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product $0.00 | $0.00 |
| 2025-09-30 | Not split by product $0.00 | $0.00 |
| 2025-06-30 | Not split by product $0.00 | $0.00 |
| 2025-03-31 | Not split by product $800.00K 100.00% | $800.00K |
| 2024-12-31 | Not split by product $0.00 | $0.00 |
| 2024-09-30 | Not split by product $3.50M 100.00% | $3.50M |
| 2023-12-31 | Not split by product $659.00K 100.00% | $659.00K |
| 2023-09-30 | Not split by product $1.19M 100.00% | $1.19M |
| 2023-06-30 | Not split by product $2.00M 100.00% | $2.00M |
| 2023-03-31 | Not split by product $5.31M 100.00% | $5.31M |
| 2022-12-31 | Not split by product $5.45M 100.00% | $5.45M |
| 2022-09-30 | Not split by product $6.40M 100.00% | $6.40M |
| 2022-06-30 | Not split by product $382.00K 100.00% | $382.00K |
| 2022-03-31 | Not split by product $3.38M 100.00% | $3.38M |
| 2021-12-31 | Not split by product $20.22M 100.00% | $20.22M |
| 2021-09-30 | Not split by product $3.75M 100.00% | $3.75M |
| 2021-06-30 | Not split by product $3.55M 100.00% | $3.55M |
| 2021-03-31 | Not split by product $3.47M 100.00% | $3.47M |
| 2020-12-31 | Not split by product $65.00K 100.00% | $65.00K |
| 2020-09-30 | Not split by product $2.83M 100.00% | $2.83M |
| 2020-06-30 | Not split by product $3.07M 100.00% | $3.07M |
| 2020-03-31 | Not split by product $3.23M 100.00% | $3.23M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |